Chief Executive Officer (CEO) – Biotechnology Spin-Off
| Research Field: |
Other |
| Sub Research Field: |
|
Job Summary
We are seeking an entrepreneurial Chief Executive Officer (CEO) to co-lead the company alongside the Founding CTO. The CEO will be responsible for driving business development, fundraising, and the go-to-market strategy. Working in close partnership, the CEO and CTO will shape and execute the overall strategic vision, translating cutting-edge research into a scalable and impactful commercial solution.
We are launching an innovative biotechnology spin-off rooted in years of cutting-edge academic research. Our mission is to transform cell culture monitoring and optimization through advanced microbioreactor platforms, real-time spectroscopic analysis, and machine learning-powered data interpretation. The initial focus lies in advanced immunotherapy and cell-based pharmaceutical development.
Job Description
Our company will deliver a portfolio of chip-based fluidic devices, next-generation sensors, automated monitoring, and data-driven services designed to enhance therapeutic outcomes and accelerate pharmaceutical innovation. With a strong technological foundation, we are ready to move from lab to market.
Key Responsibilities:
- Strategic Leadership & Company Building
- Business Development & Partnerships
- Fundraising & Investor Relations
- Market Analysis & Commercial Strategy
- Operations & Financial Oversight
- Regulatory & Quality Affairs
- Technology & Product Development
Required Qualifications:
• Master’s degree in business administration, Life Sciences, Biomedical Engineering, or related fields. Dual scientific-business background is a plus, but not necessary.
• Leadership experience in biotech, healthtech, or technology-driven startups — ideally as CEO, CSO, or similar roles — with proven involvement in early-stage growth, company formation, or successful exits.
• Strong track record in fundraising, especially with venture capital, angel investors, and public funding (e.g., Horizon Europe, CDTI, EIC Accelerator).
• Excellent command of Spanish and English, with outstanding negotiation and communication skills, particularly in investor and partner-facing settings.
• Established network in the biotech/pharma ecosystem, including access to investors, KOLs, and strategic industry players.
• Strategic and execution-driven, capable of turning vision into milestones and managing the business roadmap.
• Familiarity with biotech product development, regulatory planning (EMA/FDA),and the commercial landscape of advanced therapies or biomanufacturing is desirable.
• Highly collaborative mindset, with a strong capacity to share responsibilities, respect complementary roles, and align efforts with team for the benefit of the company’s mission and growth.
Preferred Experience:
• Familiarity with cell culture, spectroscopy, and/or machine learning in life sciences, particularly in contexts where data-driven decision making supports experimental or clinical outcome.
• Experience in launching or co-leading a biotech company, academic spin-off, or innovation-driven startup.
• Familiarity with automation, lab-on-chip technologies, or biosensor integration.
• Understanding of regulatory pathways for medical or diagnostic devices (e.g., FDA, EMA), including experience navigating CE marking or ISO standards.
This is a unique opportunity to co-lead a deep-tech, high-impact biotechnology startup from the ground up. As CEO, you will play a foundational role in building the company’s business engine and driving it to market. If you are ready to take on a transformative leadership role and build the next breakthrough in biotech innovation, we’d love to hear from you.
Full version of the offer and link to apply are available here: https://www.nanogune.eu/en/nanogune/join-us/open-position/502-chief-executive-officer-ceo-biotechnology-spin
Benefits
Comment/web site for additional job details